WallStreetZenWallStreetZen

How to Buy Biogen Stock

Biogen Inc

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases.

Biogen stock last closed at $300.20, down 0.73% from the previous day, and has increased 51.23% in one year. It has overperformed other stocks in the Drug Manufacturers - General industry by 0.41 percentage points. Biogen stock is currently +59.23% from its 52-week low of $188.54, and -6.11% from its 52-week high of $319.74.

As of Jun 2, 2023, there are 144.74M BIIB shares outstanding. The market value of BIIB is $43.45B. In the past 24 hours, 812,310 BIIB shares were traded.

How to Buy Biogen Stock

Not sure how to invest in Biogen stock? Here's how.
  1. Decide where to buy Biogen stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you decide where to buy Biogen stock.
  2. Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Deposit funds into your brokerage account: Choose your payment method and add your info.
  4. Analyze Biogen stock: The Biogen ticker symbol is BIIB. Is Biogen stock a good investment? Should you buy shares of BIIB? How do BIIB's underlying business fundamentals look? Do top analysts think Biogen is a good buy? Why has BIIB's stock price moved recently? (Hint: Our stock research tools can help you understand if BIIB is a good stock to buy).
  5. Place your BIIB trade: Decide if you will purchase BIIB shares at the current market price or use a limit order to purchase BIIB shares at a specific price.
  6. Watch your BIIB investment: Create a watchlist to track your new investment in Biogen stock.

Step 1: Decide where to buy Biogen stock

You will need an online brokerage account in order to access the NASDAQ market and buy BIIB shares.

A brokerage account allows you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

In our opinion, eToro is the best stock brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to world markets: From Technology to Energy, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by creating an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've chosen the right brokerage, you'll need to fill out some personal information so you can invest in BIIB today.

How to Create a New Account on eToro

  1. Click here to get started.
  2. Provide your personal data to start a new trading account.
  1. Send your data by pressing the "Create Account" button.
Get started with eToro today

Step 3: Deposit funds into your brokerage account

Now that you've filled out your info on the stocks app, you need to deposit funds:

Check out the walkthrough below to see the process of transferring money into your new brokerage account.

Get started with eToro today

Step 4: Analyze Biogen stock

After you have decided on the best place to buy Biogen stock, it's crucial to analyze their stock before you invest, so you can wrap your head around the risk as well as the opportunity.

Biogen stock data

BIIB Price
$300.20
1w %
0.52%
1y %
51.23%
5y %
0.43%
P/E
13.87x
P/B
3.15x
P/S
4.29x
PEG
N/A
Revenue
$10.10B
Earnings
$3.13B
Fore. Rev. Growth
-2.39%
Fore. Earn. Growth
-7.25%
Market Cap
$43.45B
Next Earnings
Jul 18, 2023
Next Dividend
N/A

BIIB Overview

WallStreetZen was built to help part-time investors do better fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on BIIB's stock page.

Is BIIB stock undervalued?

Investors use many financial metrics, analyses, models, and charts to gauge BIIB's intrinsic value.

Using relative valuations metrics:

  • BIIB could be undervalued based on its P/E ratio of 13.87x, relative to Drug Manufacturers - General industry P/E ratio of 32.55x
  • BIIB could be undervalued based on its P/B ratio of 3.15x, relative to Drug Manufacturers - General industry P/B ratio of 5.16x

You can do more valuation analysis on BIIB's stock here.

BIIB Financial Health

Pros:

  • BIIB profit margin has gone up from 13.4% to 31% in the past year.
  • There are more short-term assets than long-term liabilities on the BIIB balance sheet.
  • Total BIIB debt is lower than 5 years ago, relative to shareholder equity.
  • BIIB's operating cash flow of $1.68B allows it to safely service it's debt of $6.61B.
  • BIIB earnings of $3.69B is not sufficient to cover its interest payments.
  • There are more short-term assets than short-term liabilities on the BIIB balance sheet.

Cons:

  • BIIB has a relatively high debt to equity ratio of 0.78.

Is BIIB stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 16 Wall Street analysts who monitor BIIB, the consensus analyst rating on BIIB is a Buy

It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.

Most Recent BIIB Analyst Upgrades/Downgrades

Brian Abrahams, a top 2% analyst from RBC Capital reiterates BIIB with a buy rating and maintains their BIIB price target from $340.00 to $340.00, on Jun 2, 2023.

Christopher Raymond, a top 24% analyst from Piper Sandler maintains BIIB with a strong buy rating and raises their BIIB price target from $346.00 to $360.00, on Jun 1, 2023.

Maintaining his Strong Buy rating, Raymond raised his price target on Biogen Inc. by 4.1%.

Given zuranolone's* "fast approaching" PDUFA date for MDD/PPD on 2023/08/05, "now is the time" to factor the drug into his model, the analyst said.

His FY 2024 - 2026 total revenue estimates for zuranolone are $200M, $570M, and $890M, respectively, Raymond detailed, citing "consultations with key opinion leader physicians in the space."

* Zuranolone (SAGE-217/BIIB125) is a once-daily, 14-day, investigational drug in development for the treatment of major depressive disorder (MDD) and postpartum depression (PPD). The application has been granted priority review and the FDA has assigned a Prescription Drug User Fee Act (PDUFA) action date of 2023/08/05. [from here]

Laura Chico, a bottom 4% analyst from Wedbush reiterates BIIB with a hold rating and maintains their BIIB price target from $263.00 to $263.00, on May 23, 2023.

Jasper Hellweg, a top 14% analyst from Argus Research maintains BIIB with a strong buy rating and raises their BIIB price target from $320.00 to $350.00, on May 11, 2023.

Geoff Meacham, a bottom 10% analyst from Bank of America maintains BIIB with a hold rating and raises their BIIB price target from $300.00 to $320.00, on May 4, 2023.

You can dig deeper into what analysts are forecasting on the Biogen stock forecast page.

BIIB Momentum

SMA10
301.36
SMA20
306.23
SMA50
294.99
SMA100
286.33
SMA200
272.54
MACD
0.43
MACD Signal
2.18
MACD Histogram
-1.75
RSI
48.61
Stochastic %K
38.16
Stochastic %D
33.01
StochRSI %K
22.46
StochRSI %D
15.04

BIIB Growth Numbers

Last year, BIIB earnings were $3.13B. Over the last five year, BIIB's earnings have grown by 9.04% per year. This was slower than the Drug Manufacturers - General industry average of 29.23%.

Last year, BIIB revenue was $10.10B. In the last 5 year, BIIB's revenue has gone up by -4.31% per year. This was slower than the Drug Manufacturers - General industry average of 7.67%.

Dive into BIIB's earnings and revenue performance here.

Are BIIB insiders buying or selling the stock?

Over the last 12 months, executives and large shareholders at BIIB have sold more shares than they have bought.

Ginger Gregory, EVP Human Resources of BIIB, was the latest BIIB insider to sell. They sold $804,300.00 worth of BIIB shares on Apr 28, 2023.

Dig into more about who owns BIIB stock here.

Can I get consistent income from BIIB stock?

No, Biogen doesn't provide an income stream by paying out dividends.

BIIB Social Trading Data

One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to learn what other investors have to say.

Step 5: Place your BIIB trade

You have two main options:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are generally fine.
  • Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at a given price, use a limit order.

Hit the Open button and your broker will place your order.

If you want additional help with investing in stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Watch your BIIB investment

Now that you own some BIIB shares, you'll want to stay up-to-date on your new company.

Make a watchlist to see the latest developments about your BIIB stock.

BIIB Feed

How to Buy Stock in Biogen

To summarize, here are the 6 steps for buying Biogen stock:

  1. Decide where to buy Biogen stock
  2. Sign up for a brokerage account
  3. Deposit funds into your brokerage account
  4. Analyze Biogen stock
  5. Place your BIIB trade
  6. Watch your BIIB investment

If you need a brokerage, eToro is our recommended option.

Get Started with eToro Today

If you would like to watch your new investment in Biogen, add BIIB to your watchlist below.

NASDAQ: BIIB
$300.20-2.21 (-0.73%)
Updated Jun 2, 2023
Open eToro Account
NASDAQ: BIIB
$300.20-2.21 (-0.73%)
Updated Jun 2, 2023
Open eToro Account

FAQ

How much does it cost to buy one Biogen share?

As of Jun 2, 2023, it costs $300.20 to buy one share of Biogen stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.333 shares of BIIB.

Get Started with eToro Today

Is now a good time to buy Biogen stock?

According to 16 Wall Street analysts who monitor Biogen, their consensus recommendation is to buy Biogen stock.

What is the best way to buy Biogen stock?

One way to place an order for Biogen stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.